首页> 外国专利> A multi-target fusion protein that blocks the proliferation of vascular endothelial cells and activates T cells, and pharmaceutical compositions containing them.

A multi-target fusion protein that blocks the proliferation of vascular endothelial cells and activates T cells, and pharmaceutical compositions containing them.

机译:一种阻止血管内皮细胞增殖并激活T细胞的多靶点融合蛋白,以及含有它们的药物组合物。

摘要

The present invention blocks the proliferation of vascular endothelial cells and activates T cells, including the vascular endothelial growth inhibitor domain (i), immunoglobulin Fc domain (ii), and CD80 extracellular domain (ECD) (iii). Provides a multi-target fusion protein. The present invention comprises a polynucleotide encoding the multi-target fusion protein, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, and a pharmaceutical composition comprising the multi-target fusion protein and an anti-PD-1 antibody. We are offering more things. The multi-target fusion protein and pharmaceutical composition of the present invention can treat or prevent a cancerous disease in an individual. [Selection diagram] FIG. 4
机译:本发明阻止血管内皮细胞的增殖并激活T细胞,包括血管内皮生长抑制结构域(i)、免疫球蛋白Fc结构域(ii)和CD80胞外结构域(ECD)(iii)。提供多靶点融合蛋白。本发明包括编码多靶点融合蛋白的多核苷酸、包含该多核苷酸的载体、包含该多核苷酸或载体的宿主细胞,以及包含该多靶点融合蛋白和抗PD-1抗体的药物组合物。我们提供了更多的东西。本发明的多靶点融合蛋白和药物组合物可在个体中治疗或预防癌症疾病。[选择图]图4

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号